Qiagen (NASDAQ: QGEN) reported Q1 EPS of $0.20, $0.01 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $307.7 million versus the consensus estimate of $306.89 million.

QIAGEN reaffirms full-year 2017 outlook for 6-7% CER sales growth and adjusted EPS target before restructuring costs of $1.25-1.27 CER

For earnings history and earnings-related data on Qiagen (QGEN) click here.